ARCHIVES

Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me

This article is from The Cancer Letter archive.

Vol. 39 No. 46 | December 13, 2013

Download PDF Visit The Full Archive

Related Articles

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

ASRO President Tells Colleagues To Take Charge

October 26, 1990

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

In Brief: Frederickson Resigns As NIH Director, Says He Wants “One More Career: As Scientist, Physician

June 25, 1981

Frederick Center Should Have Top Scientist As Director, 20% Of Budget or Basic Research

December 21, 1973